Nova Materials Technology is the distributor of Jiashuo Biomedical's rapid screening reagents in Taiwan and the agent for Korean rapid screening reagents that can effectively detect BA4/BA5 viruses.

Nova Materials Technology is the distributor of Jiashuo Biomedical's rapid screening reagents in Taiwan and the agent for Korean rapid screening reagents that can effectively detect BA4/BA5 viruses.
South Korea GenBody COVID-19 Ag Antigen Rapid Screening <Enterprise Edition>
Jiebaoding COVID-19 at-home rapid antigen screening test reagent <Home version>

 
Nova Materials is an officially authorized corporate group purchasing channel distributor for Jiashuo Biomedical. Jiashuo Biomedical has introduced two rapid screening reagents from South Korea.Can effectively detect BA4 and BA5 new coronaviruses, available to major enterprises for purchase, with discounts for large quantities. During the epidemic, the implementation of corporate screening is the first line of defense to protect the company and employees. It can detect infected persons at the first time and take immediate isolation measures to prevent the spread of the virus within the company and ensure that the company can continue to operate normally.
           
▲Nova distributes the rapid screening reagents introduced by Jiashuo Biomedical.
   
 ▲Nova distributes two rapid screening reagents to provide self-screening for major companies
 
GenBody COVID-19 Ag Antigen Rapid Screening
<Enterprise Edition > 25In/box

• Model: COVAG025。
• Have EU CECertification, Korean KFDA license, Taiwan TFDA EUApassEpidemic prevention project approval input No. 1106809136。
• Sensitivity/The specificity is better than other brands of GenBody COVID-19 antigen rapid screening reagents.

Jiebaoding COVID-19 at-home antigen rapid screening test reagent
<Home version> 2 pieces/box

• Model: COVATT2-1.
• Has Korean KFDA license and Taiwan TFDA EUA passedEpidemic prevention project approval input No. 110801477。
• One box contains two tests, ready for home use during epidemic prevention (storage period is two years).
• The sensitivity/specificity is better than other brands of GenBody COVID-19 antigen rapid screening reagents.
• Clinical trial data: sensitivity 95.89%, specificity 100%.

Nova has received a large number of demands from various companies at the beginning of this year. Now the epidemic has not yet seen the light of the day, and may even break out again at any time. Nova and Jia Shuo Biomedical are working together to contribute to Taiwan's epidemic prevention. It is recommended that major companies perform rapid screening at least once a week to ensure the safety of all colleagues, reassure employees and the company, and improve workplace epidemic prevention response.
 
Nova Materials Technology (Taoshi Drug Dealer No. 623201L439) welcomes companies in need to click on the GOOGLE form to order →https://forms.gle/Te7fo26vndZCdJvs5
 
In view of the spirit of "Respect God and Love People" of Chairman Yang Lianzhi of Nova, during this difficult period for the community, Nova does not charge additional delivery fees and will ship the goods within three days after receiving the order. I would like to express my greatest sincerity to everyone in order to inspire others. I hope that under the difficulties, all walks of life can establish a good cycle and support each other to survive the difficult epidemic.



#快sieve #EnterpriseQuickScreen #nova #NOVAX #Automotive Urea #AdBlue #urea #urea solution